NEW YORK (GenomeWeb) – Investment banks Mizuho Securities and William Blair today downgraded Bruker's shares, following the company's announcement that CFO Charles Wagner is resigning effective June 12. 

Mizuho downgraded Bruker to a Neutral rating from a previous Buy rating, while William Blair downgraded the firm to Market Perform from Outperform. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.